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ABSTRACT Bacterial conjugation, a mechanism of horizontal gene transfer, is the
major means by which antibiotic resistance spreads among bacteria (1, 2). Conjuga-
tive plasmids are transferred from one bacterium to another through a type IV se-
cretion system (T4SS) in the form of single-stranded DNA covalently attached to a
protein called relaxase. The relaxase is fully functional both in a donor cell (prior to
conjugation) and recipient cell (after conjugation). Here, we demonstrate that the
protein substrate has to unfold for efﬁcient translocation through the conjugative
T4SS. Furthermore, we present various relaxase modiﬁcations that preserve the func-
tion of the relaxase but block substrate translocation. This study brings us a step
closer to deciphering the complete mechanism of T4SS substrate translocation,
which is vital for the development of new therapies against multidrug-resistant
pathogenic bacteria.
IMPORTANCE Conjugation is the principal means by which antibiotic resistance
genes spread from one bacterium to another (1, 2). During conjugation, a covalent
complex of single-stranded DNA and a protein termed relaxase is transported by a
type IV secretion system. To date, it is not known whether the relaxase requires un-
folding prior to transport. In this report, we use functional assays to monitor the
transport of wild-type relaxase and variants containing unfolding-resistant domains
and show that these domains reduce conjugation and protein transport dramati-
cally. Mutations that lower the free energy of unfolding in these domains do not
block translocation and can even promote it. We thus conclude that the unfolding
of the protein substrate is required during transport.
KEYWORDS T4SS, transport, conjugation, secretion systems, type 4 secretion
systems, unfolding
Bacteria have evolved a diversity of specialized secretion systems that allow them totranslocate macromolecules across the cell envelope (3). Among them, the type IV
secretion system (T4SS) is the most versatile (4). T4SSs mediate the transfer of DNA and
protein substrates across the cell envelope. The largest and most widely distributed of
the T4SS subfamilies are conjugation systems (5).
Conjugation is a major mechanism of horizontal gene transfer (6, 7). It is a process
by which one bacterium, the donor, transfers genetic material to another bacterium,
the recipient, in a contact-dependent manner (8). Thus, conjugation is the major means
by which antibiotic resistance genes spread among bacterial populations (1, 2). Con-
jugation occurs widely among Gram-negative bacteria, Gram-positive bacteria, and
even some archaea (9).
Many plasmids and integrative and conjugative elements (ICEs), so-called “mobile
elements,” undergo conjugation (10). Many of these mobile genetic elements are
self-transmissible: they encode the entire machinery necessary for their transfer into
recipient cells. Proteins necessary for conjugation assemble into two complexes: a
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DNA-processing complex called the relaxosome and a complex responsible for transfer,
the T4SS. The relaxosome is an assembly of a protein called relaxase and a few
accessory proteins that bind a speciﬁc DNA sequence called oriT (origin of transfer) to
form a nucleoprotein complex (11). The T4SS is a large (3 to 4 MDa) protein complex
consisting of a transport apparatus that spans the bacterial cell envelope (12), a pilus
that extends from the cell surface (13) and mediates contact between cells (14), and a
type IV coupling protein (T4CP) (15, 16) that recruits the relaxosome to the secretion
channel.
The general mechanism of conjugation is still poorly understood, but some steps are
known (11, 17). The relaxase encoded by a number (but not all) of plasmids is an
enzyme that often has two activities, transesterase/nicking activity and helicase activity.
The transesterase nicks the plasmid DNA strand destined for transfer (T-strand) at a
speciﬁc position within oriT, called nic, and remains covalently attached through a
catalytic tyrosine to the 5=-phosphate end of the cleaved strand. The relaxase and
accessory proteins carry translocation signals for recruitment of the transfer interme-
diate to the T4SS via T4CP. Upon contact with a recipient cell, the substrate (the
relaxase covalently attached to the T-strand) is transported into the recipient cell in an
ATPase-dependent manner. During the translocation process, the T-strand is unwound
from its complementary strand by a second copy of the relaxase, the helicase activity
of which motors the T-strand through the T4SS, presumably assisted by some of the
T4SS ATPases (18). In the recipient cell, the relaxase molecule that has passed through
the system may recircularize the T-strand, and the complementary strand is synthesized
(17).
R388 is one of the best-studied conjugative plasmids that belong to a broad-host-
range group of plasmids (19, 20). Proteins essential for conjugation are encoded within
two separate gene clusters. One cluster contains oriT and genes encoding the accessory
protein TrwA, the T4CP protein TrwB, and the relaxase TrwC, whereas the other cluster
encodes 11 T4SS proteins, TrwN to TrwD (TrwN-TrwD), homologs of the VirB1 to VirB11
(VirB1-VirB11) proteins of the prototypical T4SS from Agrobacterium tumefaciens, the
VirB/D4 system (21, 22).
The TrwC relaxase is a 107-kDa protein composed of two domains: an N-terminal
transesterase (also termed “relaxase”) domain (approximately 1 to 300 residues) and a
C-terminal helicase domain (approximately 300 to 966 residues). High-resolution crystal
structures of the TrwC relaxase domain in complex with oligonucleotides containing
TrwC binding and/or nicking sites revealed details of DNA binding site recognition and
a nicking mechanism by TrwC (23, 24). Nucleophilic attack of the nic site by the catalytic
tyrosine, Tyr18 (25), generates a phosphotyrosine bond between the cleaved T-strand
5=-phosphate and the Tyr residue in the relaxase. The C terminus of TrwC (residues 796
to 802) contains a translocation signal for recruitment by the T4SS machinery (26). The
helicase domain contains a 5=–3= helicase activity (27). Once in the recipient cell, the
helicase domain is thought to track in the 5= to 3= direction along the T-strand in order
to position it correctly for the termination rejoining step (28). It is also thought to be
responsible for the unwinding of the T-strand during conjugation. In this case, the
T-strand-unwinding TrwC molecule would have to be distinct from the translocated
one (18).
The fact that the relaxase has to pass through the T4SS raises the question of
whether the relaxase is transported in a folded or unfolded state through the T4SS
channel. Among other types of bacterial secretion systems, some are known to trans-
port folded substrates (such as type 2 secretion systems [29] and the chaperone-usher
pathway [30, 31]), whereas some can translocate only unfolded substrates (e.g., type 1
secretion systems [32] and type 3 secretion systems [33, 34]). The negative-stain
electron microscopy structure of the TrwM/VirB3-TrwE/VirB10 complex from R388 T4SS
has recently revealed the T4SS architecture (12). However, the internal channel, the
dimensions of which might give a clue on the folding state of the substrate during
transport, has not yet been identiﬁed. In this report, we have studied the requirements
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for the substrate translocation by the R388 conjugative T4SS. We show that the T4SS
substrates have to be unfolded in order to be translocated into recipient cells.
RESULTS
The overall aim of this study is to investigate whether transport of the relaxase
requires unfolding of the protein. In order to answer this question, our strategy was to
fuse unfolding-resistant proteins or protein modules of various sizes to TrwC and test
if they can be transported into recipient cells. We ﬁrst sought to test this by directly
monitoring the transport of the protein itself during conjugation using the previously
described Cre recombinase reporter assay for translocation (CRAfT [35, 36]).
Establishing a translocation assay of the TrwC relaxase based on the CRAfT
assay. Brieﬂy, the recipient strain contains a chloramphenicol resistance gene inter-
rupted by a tetracycline resistance cassette ﬂanked by loxP sites. Therefore, the strain
is tetracycline resistant, but upon Cre recombination, it becomes tetracycline sensitive
and chloramphenicol resistant. The transfer of Cre recombinase-substrate fusion can be
measured by measuring the change in antibiotic resistance of recipient cells upon
conjugation. We used a two-plasmid system composed of a plasmid containing R388
oriT, termed pRSF-oriT, and a plasmid encoding relaxosome components (TrwA, TrwB,
and TrwC) and T4SS, termed pBAD-ABC-T4SS. This two-plasmid system typically re-
sulted in 60 to 80% of the recipients acquiring the oriT plasmid (transconjugants) in our
conjugation assay.
We ﬁrst fused the Cre recombinase at different locations within the TrwC substrate
and tested which construct retains functionality (both in plasmid conjugation and Cre
recombination). Cre recombinase was fused to the TrwC N terminus (termed Cre-TrwC),
TrwC C terminus (termed TrwC-Cre), and between the relaxase and helicase domains
(termed R-Cre-H) (Fig. 1A). Given the fact that the ﬁrst methionine (Met1) of the
N-terminal relaxase domain is located at the center of the relaxase structure and
participates in DNA binding, together with Leu2, His4, Met5, and Val6 (24), there was a
possibility that the N-terminal fusion would abolish oriT binding and/or nicking and,
therefore, conjugation. Nevertheless, TrwC transfer without DNA transfer has previously
been observed (37); thus, we proceeded with making and testing all three Cre fusions
of TrwC, even the N-terminal fusion.
Cre recombinase retained functionality in all three fusions (Fig. 1B). Surprisingly, the
conjugation level of all three fusions was high, even for the N-terminal fusion; however,
protein transfer was detected only in the case of Cre-TrwC and R-Cre-H (Fig. 1C). Since
TrwC-Cre is not transported into the recipient cells at detectable levels, the high
conjugation efﬁciency observed with this construct is most likely due to a fraction of
TrwC lacking the C-terminal Cre fusion, a result of proteolytic degradation within the
cell.
Cre-TrwC displays a high level of conjugation, indicating that N-terminal fusions of
TrwC might be active in DNA transport after all. We therefore tested puriﬁed TrwC with
and without N-terminal fusions in an oriT nicking assay. As shown in Fig. 2, whereas
TrwC-His6 formed a covalent linkage with the pUC-oriT plasmid, we did not detect any
monomeric green ﬂuorescent protein-TrwC (mGFP-TrwC), or even GA-TrwC (TrwC with
an additional N-terminal glycine and alanine residue), covalently bound to oriT. Since
even only two additional N-terminal residues can abolish TrwC activity, the source of
TrwC protein that is functional in conjugation is most likely wild-type TrwC coexpressed
starting from the original start codon. The linker sequence between Cre and TrwC that
lies just upstream of the TrwC start codon is rich in GG nucleotides, possibly acting as
a ribosome-binding site. In conclusion, both N-terminal and C-terminal fusions abolish
TrwC transport and/or activity.
Unlike the N-terminal and C-terminal Cre fusions, which can both apparently yield
a Cre-less wild-type version of the protein (see above), the internal Cre fusion construct
cannot undergo modiﬁcations yielding wild-type TrwC. Indeed, separated relaxase and
helicase domains that could arise by proteolytic degradation are not functional (27, 38).
Therefore, the measured conjugation efﬁciency of R-Cre-H reﬂects the activity of the
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full-length protein. R-Cre-H also showed almost two orders of magnitude higher level
of protein translocation in the CRAfT experiment than Cre-TrwC (Fig. 1C). Since
Cre-TrwC is not functional in oriT nicking, the protein is in this case transported without
being attached to the T-strand, as described by Draper et al. (37). In order to test if oriT
binding is the reason for higher protein translocation of R-Cre-H, we repeated the
CRAfT assay but this time excluding the pRSF-oriT plasmid. Surprisingly, we detected
higher protein transport in the absence of the oriT plasmid than in its presence
(Fig. 1D). This indicates that the Cre recombination in recipient cells might be affected
by the presence of the T-strand, possibly due to competition with the TrwC helicase
activity along the T-strand.
Substrate unfolding is a prerequirement for translocation through T4SS. Next,
we chose the N-terminal fusions to test the extent of substrate unfolding required for
its transport through the T4SS. We fused a set of “unfoldable” (here meaning “that can
be unfolded”) and unfolding-resistant (that cannot be unfolded) proteins between Cre
and TrwC (Fig. 3A) and tested if they can be transported into recipient cells. With Cre
recombinase positioned at the very N terminus and TrwC translocation signal at the
very C terminus, these constructs allow us to detect the transport of only full-length
proteins. Ubiquitin (Ub; 8 kDa) and GFP (27 kDa) have been reported to be resistant to
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FIG 1 Establishing a Cre recombinase reporter assay for translocation of R388 T4SS substrates. (A) Scheme of TrwC constructs with Cre recombinase fusion at
different positions. (B) Recombination efﬁciency of Cre recombinase fused to the TrwC N terminus (Cre-TrwC), TrwC C terminus (TrwC-Cre), and between the
relaxase and helicase domains (R-Cre-H) when expressed in recipient cells. Values represent the mean  standard error of the mean (SEM) of the results from
four experiments. Unpaired t test showed no signiﬁcant difference between recombination efﬁciencies of Cre-TrwC, R-Cre-H, and TrwC-Cre (P  0.05). (C)
Conjugation and protein translocation efﬁciency of cells carrying pRSF-oriT and pBAD-ABC-T4SS plasmid encoding modiﬁed TrwC, as indicated. The efﬁciencies
are expressed as a fraction of recipient cells that acquired pRSF-oriT plasmid (transconjugants) and TrwC fusion protein (recombinants), respectively. Values
represent the mean  SEM of the results from three experiments. Statistically signiﬁcant differences (unpaired t test) between wild-type and Cre fusion
construct conjugation frequencies are indicated. ***, P  0.001. (D) The comparison of TrwC translocation in the presence (red bars) or absence (gray bars) of
pRSF-oriT plasmid. The protein translocation efﬁciencies are expressed as a fraction of recipient cells that acquired the indicated TrwC fusion protein. Values
represent the mean  SEM of the results from four experiments. Statistically signiﬁcant differences (unpaired t test) between translocation frequencies in the
presence or absence of oriT are indicated. ***, P  0.001.
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unfolding, whereas the ubiquitin mutant UbI3G,I13G (Ub3,13) served as the unfoldable
protein control (34, 39). We ﬁrst tested the Cre recombinase activity of these constructs.
Cre recombinase was functional in all fusions tested (Fig. 3B).
When tested in the CRAfT assay, the protein construct containing the unfoldable
fusion, the ubiquitin mutant (Ub3,13), was transported into recipient cells at very high
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FIG 2 N-terminal fusions abolish TrwC nicking of oriT. (A) Sypro Ruby-stained SDS gel showing puriﬁed
TrwC-His6, GA-TrwC (glycine-alanine-TrwC), and mGFP-TrwC free or covalently bound to pUC-oriT.
Constructs with 40, 80, or 160 nM TrwC were incubated at 37°C for 30 min with 40 nM pUC-oriT before
the nicking reaction was stopped by adding SDS sample buffer and EDTA and heating at 95°C. (B)
TrwC-His6 nicks oriT speciﬁcally. TrwC-His6 at 50 nM (lanes 1 and 3) or 100 nM (lanes 2 and 4) was
incubated with either pUC-oriT or pUC18 plasmid (20 nM), as indicated, at 37°C for 30 min before the
reaction was stopped by adding SDS sample buffer and EDTA and heating at 95°C.
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FIG 3 TrwC unfolding is necessary for its translocation through the T4SS. (A) Scheme of TrwC constructs
with N-terminal Cre recombinase followed by an unfoldable (Ub3,13) or unfolding-resistant (Ub and
mGFP) fusion. (B) Recombination efﬁciency of Cre recombinase fused to the N terminus of the indicated
protein followed by TrwC when expressed in recipient cells. Values represent the mean  SEM of the
results from three experiments. Statistically signiﬁcant differences (unpaired t test) between recombi-
nation efﬁciencies of Cre-TrwC and constructs with an additional fusion are indicated. *, P  0.05;
**, P  0.01; ***, P  0.001. (C) Protein translocation efﬁciency of cells carrying pBAD-ABC-T4SS plasmid
encoding modiﬁed TrwC, as indicated. Values represent the mean  SEM of the results from four
experiments. Statistically signiﬁcant differences (unpaired t test) between protein translocation efﬁcien-
cies of Cre-TrwC and constructs with an additional fusion are indicated. *, P  0.05; **, P  0.01;
***, P  0.001.
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levels (10% of the recipient cells underwent recombination) (Fig. 3C). In comparison,
its wild-type ubiquitin counterpart was transported at a level of about ﬁve orders of
magnitude lower, similar to the level of the construct containing mGFP. These data
clearly demonstrate that the conjugative T4SS substrate, the relaxase protein, has to be
unfolded in order to pass through the T4SS channel.
Relaxase constructs that block substrate translocation in the native plasmid.
The experiments described above were conducted using an artiﬁcial two-plasmid
system reporting on protein transport to the recipient cell. We sought next to monitor
the nucleoprotein substrate transport through conjugative T4SS using the native R388
plasmid. We also sought to expand the range of fusion proteins probed. For this
purpose, it was necessary to generate a modiﬁed protein substrate that is fully
functional. We therefore generated three different sets of relaxase constructs and
tested their functionality. For these experiments, we directly modiﬁed TrwC in the
wild-type R388 plasmid. Since N-terminal fusions abolish oriT nicking activity, we tested
if duplicating the relaxase domain in front of the N-terminal fusion can recover relaxase
activity (Fig. 4A, left). In order to avoid expression of the wild-type TrwC from its original
start codon, the ﬁrst methionine in the second relaxase domain was deleted. Indeed,
the addition of the relaxase domain in front of the unfoldable ubiquitin fusion resulted
in wild-type levels of relaxase activity (Fig. 4A, right). The high conjugation efﬁciency of
this construct is not the result of proteolysis of mutant ubiquitin (see Fig. S1 in the
supplemental material). Replacing an unfoldable fusion with an unfolding-resistant one
efﬁciently blocks the substrate transport, resulting in more than two orders of magni-
tude lower conjugation efﬁciency (Fig. 4A, right).
Equivalently, an attempt was made to recover the activity of C-terminal fusions by
adding another helicase domain (H) to the C terminus of a TrwC-fusion (Fig. 4B, left). In
this case, the duplication of the helicase domain did not completely restore the
wild-type level of relaxase activity (Fig. 4B, right), potentially due to the suboptimal
position of the translocation signal (e.g., too large a distance between the relaxase and
the functional translocation signal). The difference in the conjugation efﬁciencies
between the unfolding-resistant and unfoldable ubiquitin construct is lower than for
the constructs with the duplicated relaxase. The observed conjugation efﬁciency of
TrwC-Ub/mGFP-H constructs might be a result of either coexpression of the wild-type
TrwC (as a result of either degradation and/or premature translation termination) or
suboptimal folding of ubiquitin and mGFP at the TrwC C terminus.
Finally, we tested the activity of TrwC containing internal fusions between its
relaxase and helicase domains (Fig. 4C, left). Internal fusion with Ub3,13 retains a
wild-type level of activity (Fig. 4C, right). Unfolding-resistant (Ub or mGFP) fusions
efﬁciently blocked substrate transport, with conjugation efﬁciencies of more than three
orders of magnitude lower than that of its unfoldable counterpart.
We note that in all unfolding-resistant variants tested, a very low residual level of
translocation/transfer is observed, likely due to a small fraction of these proteins being
less resistant to unfolding due to defects in their folded state.
Conclusion. Secretion in bacteria is a critical process in pathogenesis and interbac-
terial competition in many bacterial pathogens. Bacteria have evolved a diversity of
specialized secretion systems to export a wide range of substrates, including small
molecules, proteins, and DNA, across the cell envelope (3). Some secretion systems,
such as the T2SS (29) and the chaperone-usher pathway (30, 31), transport fully folded
protein substrates, whereas some can transport only unfolded substrates (e.g., T1SS [32]
and T3SS [33, 34]). In this report, we demonstrate that conjugative T4SS substrates,
relaxases, have to undergo unfolding in order to be transported through the T4SS
channel. A comparison of translocation frequencies of unfolding-resistant TrwC fusions
and their unfoldable counterparts clearly demonstrated that both TrwC alone and TrwC
covalently attached to the T-strand are transported into recipient cells in an unfolded
state. In that respect, conjugative T4SSs work in a manner similar to that of effector
only-transporting T4SSs, such as that of the bacterial pathogen Legionella pneumophila
(40).
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T1SS substrates fold upon binding of calcium, which is low in the bacterial cytosol
but high in the extracellular space; therefore, it is generally assumed that T1SS
substrates adopt their folded conformation only after secretion into the extracellular
space. Conjugative relaxases are clearly folded prior to their translocation, as they are
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FIG 4 Conjugation of TrwC fusions in native R388 plasmid. (A) Duplicated relaxase domain recovers oriT nicking activity of TrwC with N-terminal fusion.
Left, scheme of TrwC constructs with duplicated relaxase domain and indicated fusion protein (termed R-X-TrwC, where X represents Ub3,13, Ub, or
mGFP). Right, conjugation efﬁciency of cells carrying R388 plasmid encoding modiﬁed TrwC, as indicated. Values represent the mean SEM of the results
from three experiments. Statistically signiﬁcant differences (unpaired t test) between wild-type and fusion construct conjugation frequencies are
indicated. ***, P  0.001. (B) Conjugation efﬁciency of TrwC-fusion-helicase constructs. Left, scheme of TrwC constructs with indicated fusion protein and
duplicated helicase domain (termed TrwC-X-H, where X represents Ub3,13, Ub, or mGFP). Right, conjugation efﬁciency of cells carrying R388 plasmid
encoding modiﬁed TrwC, as indicated. Values represent the mean  SEM of the results from three experiments. Statistically signiﬁcant differences
(unpaired t test) between conjugation frequencies of indicated pairs of constructs are shown. *, P  0.05; **, P  0.01. (C) TrwC relaxase and helicase
domains retain their functionality after being separated by an internal fusion. Left, scheme of TrwC constructs with indicated internal fusion (termed
R-X-H, where X represents Ub3,13, Ub, or mGFP). Right, conjugation efﬁciency of cells carrying R388 plasmid encoding modiﬁed TrwC, as indicated. Values
represent the mean  SEM of the results from three experiments. Statistically signiﬁcant differences (unpaired t test) between wild-type and fusion
construct conjugation frequencies are indicated. ***, P  0.001.
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fully functional when expressed in a bacterial cell. Which enzyme/unfoldase is respon-
sible for T4SS substrate unfolding remains unclear. In case of T3SS, a dedicated
hexameric ATPase has a critical function in substrate recognition and unfolding in an
ATP-dependent manner (33). T4SS, on the other hand, is energized by three distinct
hexameric ATPases: VirB4, VirB11, and T4CP. T4CP is an integral membrane protein that
interacts with the relaxase and accessory proteins and recruits the transfer intermediate
to the T4SS translocation machinery. T4CP ATPase activity is not required for the
recruitment (41). However, the activities of all three ATPases are essential for nucleo-
protein transport (41). VirB4 is an integral part of the T4SS inner membrane complex
(IMC) and is located mainly in the cytoplasm. VirB11 is a cytoplasmic ATPase that
interacts with T4CP and VirB4. Apart from being essential for substrate transport, VirB4
and VirB11 are required for T4SS pilus assembly. Due to their several roles that are
essential for T4SS function, it is difﬁcult to predict which ATPase is responsible for
substrate unfolding.
The CRAfT experiments performed here also revealed that an N-terminal fusion
might abolish a relaxase function (Fig. 1). TrwC oriT nicking activity was sensitive to the
addition of only two amino acids at its N terminus (Fig. 2). The crystal structure of the
TrwC relaxase domain in complex with its cognate DNA at oriT showed that ﬁrst ﬁve
TrwC residues participate in binding DNA (24). The N-terminal methionine alone forms
multiple interactions with DNA. Its side chain is trapped in a hydrophobic cage formed
by a sharp U-turn of the T-strand DNA, whereas its amino group forms a hydrogen bond
with the DNA. Therefore, the addition of any amino acids to the relaxase N terminus
might perturb oriT binding and result in an inactive protein.
Finally, we showed here that although the terminal fusions abolish the relaxase
activity, it is possible to modify the relaxase in different ways in order to preserve the
functionality of its domains. Placing a fusion internally or duplicating a domain can
recover a relaxase activity, and unfolding-resistant fusions can be used to efﬁciently
block the substrate transport. This will be particularly important for deciphering the
complete mechanism of T4SS substrate translocation. T4SS substrates modiﬁed with
unfolding-resistant fusions at appropriate locations could be used as a tool to efﬁciently
trap the substrate during translocation. Structural studies of the T4SS in complex with
the substrate trapped within will allow the substrate translocation path and T4SS
conformational changes necessary for translocation to be deﬁned. Deciphering the
details of the T4SS translocation mechanism will be vital to facilitate the development
of new therapies against multidrug-resistant pathogenic bacteria.
MATERIALS AND METHODS
Molecular biology. The oriT and expression plasmids used in this study are described in Table S1 in
the supplemental material. Primer sequences are shown in Table S2. DNA fragments used for cloning
were ampliﬁed using Phusion high-ﬁdelity DNA polymerase (NEB), according to the manufacturer’s
instructions. Restriction enzymes were obtained from NEB. Unless otherwise stated, the antibiotic
concentrations used were as follows: kanamycin (Km), 30 g/ml; ampicillin (Amp), 100 g/ml; tetracy-
cline (Tc), 10 g/ml; chloramphenicol (Cm), 10 g/ml; streptomycin (Sm), 25 g/ml; and trimethoprim
(Tmp), 10 g/ml.
pRSF-oriT was generated by ligation (rapid DNA ligation kit; Roche) of ampliﬁed oriT and pRSFDuet-1
vector digested with the BssHII restriction enzyme. pUC-oriT was generated by ligation of ampliﬁed oriT
and pUC18 vector digested with HindIII-HF and SacI-HF restriction enzymes.
Unless otherwise stated, all plasmids used in this study were generated by seamless cloning using the
In-Fusion HD cloning kit (Clontech). In most cases, the constructs were generated by fusing two PCR
fragments. In some cases (described below), the constructs were generated by fusing a PCR fragment
and a linearized vector. pBAD-trwN/virB1-trwE/virB10Strep-trwD/virB11 was cloned by amplifying trwD or
virB11 and inserting it into the pBAD-trwN/virB1-trwE/virB10Strep plasmid (12), which was linearized using
the BstBI restriction enzyme. pBAD-ABC-T4SS was cloned by amplifying trwABCHis and inserting it into the
pBAD-trwN/virB1-trwE/virB10Strep-trwD/virB11 plasmid, which was linearized using the NcoI restriction
enzyme. All pBAD-ABC-T4SS constructs encoding modiﬁed TrwC were cloned in the same way (by
amplifying ABC and inserting into the linearized pBAD-trwN/virB1-trwE/virB10Strep-trwD/virB11 plasmid).
TrwC internal fusions were inserted into an unstructured region between the relaxase and helicase
domains (between residues 312 and 313). The TrwC secondary structure was predicted using PSIPRED
version 3.3 (http://bioinf.cs.ucl.ac.uk/psipred/).
A ubiquitin mutant was generated using the QuikChange Lightning multisite-directed mutagenesis
kit (Agilent Technologies), according to the manufacturer’s instructions. A Cre active-site mutant was
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generated using the QuikChange Lightning site-directed mutagenesis kit (Agilent Technologies), accord-
ing to the manufacturer’s instructions.
Modiﬁcation of the wild-type R388 plasmid. The modiﬁed R388 plasmids used in this study are
described in Table S3. The R388 plasmid was modiﬁed using recombineering method according to the
multicopy plasmid modiﬁcation protocol (42, 43). The two-step seamless method using the cm-sacB
selection cassette was used to create precise genetic changes without otherwise altering the plasmid.
The cm-sacB cassette is used for positive/negative selection; it can be selected either for (by chloram-
phenicol resistance) or against (sucrose sensitivity). In the ﬁrst recombineering step, the sequence to be
modiﬁed is replaced with the cm-sacB cassette; the cassette is then replaced with the desired alteration
in the second recombineering event.
The bacterial strain containing the defective  prophage, SW102 (44), and the plasmid containing
cm-sacB cassette, pEL04, were obtained from NCI—Frederick. PCR products used for homologous
recombination contained at each end on average about 200 bp of ﬂanking homology to the desired
region on the plasmid. For this purpose, PCR templates were ﬁrst generated using In-Fusion HD cloning
kit. We ﬁrst made the templates for the second recombineering step by modifying TrwC encoded on the
pBAD-ABC vector (see Tables S1 and S2). The templates for the ﬁrst recombineering step were then
prepared by replacing a desired TrwC modiﬁcation on a relevant pBAD-ABC vector (encoding relevant
modiﬁed TrwC) with the cm-sacB cassette. PCR products were ampliﬁed from linearized templates using
Phusion high-ﬁdelity DNA polymerase (NEB), digested with DpnI, and puriﬁed using the MinElute gel
extraction kit (Qiagen). The details of the templates and PCR products are given below.
To generate an R388 plasmid encoding TrwC with a fusion protein between the relaxase (R) and
helicase domains (H), R388_R-Ub/Ub3,13/mGFP-H, the template for the ﬁrst recombineering step was
generated by replacing the relaxase and the ﬁrst part of the helicase domain in the pBAD-ABCHis plasmid
with the cm-sacB cassette, generating the pBAD-AB_Cm-SacB-H plasmid. In the ﬁrst recombineering step,
the PCR fragment containing B_Cm-SacB-H was ampliﬁed from the pBAD-AB_Cm-SacB-H plasmid and
used to modify the wild-type R388. In the second recombineering step, the PCR fragment containing
B_R-Ub/Ub3,13/mGFP-H was ampliﬁed from the pBAD-AB_R-Ub/Ub3,13/mGFP-H plasmid and used to
modify R388_B_Cm-SacB-H.
To generate a wild-type R388 plasmid encoding TrwC with duplicated domains, four recombineering
steps were necessary. The two-step approach, using a PCR product with duplicated domain sequences
in the second step, generated the R388 plasmid encoding wild-type TrwC. This is because the recom-
bineering occurs through a fully single-stranded DNA (ssDNA) intermediate of the PCR fragment (45),
most likely resulting in recombination of the duplicated domains, generating the wild-type protein.
To generate an R388 plasmid encoding TrwC with duplicated relaxase domains (R) and a fusion
protein between, R388_R-Ub/Ub3,13/mGFP-TrwC, the following PCR fragments were generated. For the
ﬁrst recombineering step, the PCR fragment encoding B_Cm-SacB-H was ampliﬁed from the pBAD-
AB_Cm-SacB-H plasmid. For the second step, the PCR fragment encoding B_R-His6-Ub/Ub3,13/mGFP-H
was ampliﬁed from the pBAD-AB_R-His6-Ub/Ub3,13/mGFP-H plasmid. For the third step, the PCR fragment
encoding Ub/Ub3,13/mGFP-Cm-SacB-H was ampliﬁed from the pBAD-AB_R-His6-Ub/Ub3,13/mGFP-Cm-
SacB-H plasmid. For the fourth step, the PCR fragment encoding Ub/Ub3,13/mGFP-TrwC was ampliﬁed
from the pBAD-AB_R-His6-Ub/Ub3,13/mGFP-TrwC plasmid.
To generate R388 plasmid encoding TrwC with duplicated helicase domains (H) and a fusion protein
between, R388_TrwC-Ub/Ub3,13/mGFP-H, the following PCR fragments were generated. For the ﬁrst step,
the PCR fragment encoding H-Cm-SacB-B11 was ampliﬁed from the pBAD-ABC-Cam-SacB-trwD/virB11
plasmid. TrwD/VirB11 is the protein encoded downstream of TrwC in the wild-type R388 plasmid. For the
second step, the PCR fragment encoding H-Ub/Ub3,13/mGFP-His6-B11 was ampliﬁed from the pBAD-
ABC-Ub/Ub3,13/mGFP-His6-trwD/virB11 plasmid. For the third step, the PCR fragment encoding Ub/
Ub3,13/mGFP-Cm-SacB-trwD/virB11 was ampliﬁed from the pBAD-ABC-Ub/Ub3,13/mGFP-Cm-SacB-trwD/
virB11 plasmid. For the fourth step, the PCR fragment encoding Ub/Ub3,13/mGFP-H-His6-trwD/virB11 was
ampliﬁed from the pBAD-AB_R-Ub/Ub3,13/mGFP-H-His6-trwD/virB11 plasmid.
Electrocompetent SW102 cells were prepared in the following way. One-and-a-half milliliters of
SW102 cells grown overnight at 30°C was diluted in 75 ml of LB medium and grown with shaking at 32°C
until reaching an optical density at 600 nm (OD600) of 0.5. The  recombination genes were induced by
placing the ﬂask into a 42°C shaking water bath for 15 min. The ﬂask was then cooled in the ice-water
slurry, and the electrocompetent cells were prepared by washing the cells twice with 40 ml of ice-cold
distilled water and resuspending in 200 l of distilled water. Fifty microliters of cells was electroporated
with 60 ng of plasmid and 100 to 150 ng of puriﬁed PCR fragment and shaken for 2 h at 30°C in 1 ml
of LB. After 2 h, 9 ml of LB medium containing 12.5 g/ml chloramphenicol (in the case of ﬁrst
recombineering step) or 10 g/ml trimethoprim (in the case of second recombineering step) was added,
and the culture was grown overnight with shaking at 30°C. The following morning, the plasmid was
isolated from the culture using the QIAprep Spin miniprep kit (Qiagen) and transformed into electro-
competent Escherichia coli TOP10 cells, and the recombined plasmid was selected on LB agar plates
containing chloramphenicol (in the case of ﬁrst recombineering step) or trimethoprim and 6% sucrose
and lacking NaCl (in the case of second recombineering step). Several Cm-resistant and sucrose-sensitive
colonies (in the case of ﬁrst recombineering step) or Cm-sensitive and sucrose- and Tmp-resistant
colonies (in the case of second recombineering step) were grown, and recombinant plasmids were
isolated and sequenced.
Cre recombination test. Prior to the CRAfT experiments described below, Cre recombinase activity
for each Cre fusion construct was tested. CSH26Cm::LTL cells (Tc resistant [Tcr]; Lang et al. [36]) carrying
pBAD-ABC (Amp resistant [Ampr]) with or without modiﬁed TrwC (as indicated in Results) were grown
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overnight in LB medium containing tetracycline, ampicillin, and 0.4% glucose. One hundred twenty-ﬁve
microliters of the overnight culture was pelleted and resuspended in 5 ml of LB medium containing
ampicillin. The culture was grown at 37°C until reaching an OD600 of 0.6. The cells were then put on ice.
Recombinants were selected by plating serial dilutions on LB agar plates containing chloramphenicol,
and the total cell counts were determined as the sum of cells growing on tetracycline plates and cells
growing on chloramphenicol plates. There were no cells growing on tetracycline and chloramphenicol
plates. The recombination frequencies are calculated as recombinants per total amount of cells.
CRAfT assay. The Cre fusion reporter assay was adapted from a study by Lang et al. (36). An
overnight culture of TOP10 donor cells carrying pRSF-oriT (Km resistant [Kmr]) and/or pBAD-ABC-T4SS
(Ampr) with or without modiﬁed TrwC (as indicated in Results) was diluted 20 in LB medium containing
appropriate antibiotics and grown at 37°C until reaching an OD600 of 0.6. The cultures were then induced
with 0.08% (vol/vol) arabinose for 1 h. In parallel, an overnight culture of CSH26Cm::LTL recipient cells
(Tcr) was diluted 40 in LB medium and grown at 37°C. Donors corresponding to an OD of 1 and
recipients corresponding to an OD of 0.1 were spun and resuspended in 50 l of LB. The mixture was
pipetted onto ﬁlter paper (MF-Millipore membrane, mixed cellulose esters, 0.45 m) lying on top of an
LB plate that was well dried beforehand. The ﬁlter was incubated at 37°C for 2.5 h and then recovered
into an Eppendorf tube. The cells were washed off the ﬁlter by adding LB medium and gently vortexing
the tube. Recombinants were selected by plating serial dilutions on LB agar plates containing chloram-
phenicol, and when pRSF-oriT was present, transconjugants were selected on LB agar plates containing
kanamycin and tetracycline. Recipient cell counts were determined as the sum of cells growing on
tetracycline plates and cells growing on chloramphenicol plates. No cells grew on tetracycline and
chloramphenicol plates. The conjugation and protein translocation frequencies are calculated as the
number of transconjugants and recombinants per recipient, respectively.
TrwC puriﬁcation. A culture of E. coli TOP10 cells carrying pBAD-ABCHis (Ampr) was grown at 37°C
from a single colony until reaching an OD600 of 0.6. Protein expression was induced with 0.08% (vol/vol)
arabinose, and the culture was incubated overnight at 18°C with shaking at 200 rpm. Cells were
harvested and resuspended in ice-cold resuspension buffer (50 mM HEPES, 15 mM imidazole [pH 7.8] at
4°C) supplemented with 0.5 mg/ml lysozyme and protease inhibitors (Complete EDTA-free; Roche). After
resuspension, the lysate was supplemented with 5 mM MgCl2 and 25 U/ml Benzonase (Merck Millipore)
and incubated for 15 min on ice. The lysate was then supplemented with 250 mM NaCl and passed
through a high-pressure homogenizer (Emulsiﬂex-C5; Avestin). The cell lysate was clariﬁed by centrifu-
gation at 100,000 g for 30 min at 4°C and applied to a 5-ml HiTrap chelating HP column (GE Healthcare)
loaded with cobalt ions and equilibrated with wash buffer (50 mM HEPES, 250 mM NaCl, 20 mM
imidazole [pH 7.8] at 4°C). The column was then washed extensively ﬁrst with wash buffer followed by
high-salt buffer A (50 mM HEPES, 500 mM NaCl [pH 7.8] at 4°C) and ﬁnally reequilibrated with wash
buffer. The protein was eluted with 10 column volumes of linear imidazole gradient (A, wash buffer; B,
50 mM HEPES, 200 mM NaCl, 500 mM imidazole [pH 8.0] at 4°C). The eluted protein was applied to a 5-ml
HiTrap SP HP column (GE Healthcare) equilibrated with low-salt buffer (50 mM HEPES, 250 mM NaCl [pH
7.8] at 4°C). The protein was eluted with 10 column volumes of linear salt gradient (A, low-salt buffer; B,
50 mM HEPES, 1 M NaCl [pH 7.8] at 4°C). The eluted protein was further puriﬁed by gel ﬁltration using
a Superdex 200 10/300 GL column equilibrated in gel ﬁltration buffer (50 mM HEPES, 500 mM NaCl [pH
7.8] at 4°C). The protein concentration was determined by measuring the absorbance at 280 nm and
using a molar extinction coefﬁcient calculated from its primary sequence (Expasy [http://expasy.org/
tools/protparam.html]). Proteins were supplemented with glycerol to a ﬁnal concentration of 20%
(vol/vol), ﬂash-frozen, and stored at 80°C.
mGFP-TrwC and GA-TrwC (TrwC with additional two residues, glycine and alanine, at its N terminus)
were puriﬁed as described above for TrwC-His6, with the following modiﬁcations. pETZt-mGFP-trwC and
pETZt-trwC (Kmr) were used to transform E. coli BL21 Star (DE3) cells. Protein expression was induced
with 0.1 mM isopropyl--D-thiogalactopyranoside (IPTG). In the case of GA-TrwC, following the ion-
exchange step, the N-terminal His6-Z tag was cleaved off during an overnight incubation at 4°C with
His6-tagged TEV protease (1 mg of protease per 30 mg of substrate). The mixture was simultaneously
dialyzed into wash buffer B (50 mM HEPES, 500 mM NaCl, 20 mM imidazole [pH 7.8] at 4°C). Cleaved
His6-Z tag and the protease were removed by rebinding to a cobalt-charged HiTrap chelating HP column
equilibrated with wash buffer B. The ﬂowthrough (containing cleaved proteins) was concentrated and
further puriﬁed by gel ﬁltration, as described above.
oriT nicking assay. To test DNA nicking by different TrwC constructs, pUC-oriT was mixed with either
TrwC-His6, GA-TrwC, or mGFP-TrwC and incubated for 30 min at 37°C. The ﬁnal mixture contained 40 nM
pUC-oriT and 40, 80, or 160 nM TrwC, and the ﬁnal binding buffer contained 30 mM HEPES (pH 7.6) at
25°C, 100 mM NaCl, and 5 mM MgCl. After incubation, the reaction mixtures were supplemented with
NuPAGE LDS sample buffer (Thermo Fisher Scientiﬁc) and EDTA at a ﬁnal concentration of 1 and 5 mM,
respectively. The samples were heated at 95°C for 5 min and loaded onto a NuPAGE Novex 4 to 12%
Bis-Tris gel (Thermo Fisher Scientiﬁc). Following SDS-PAGE, the gel was stained with Sypro Ruby protein
gel stain (Thermo Fisher Scientiﬁc), according to the manufacturer’s instructions. TrwC constructs were
visualized using a FLA-3000 ﬂuorescent imaging scanner (Fujiﬁlm).
To test its speciﬁcity of DNA nicking, TrwC-His6 was mixed with either the pUC-oriT or pUC18 plasmid
and incubated for 30 min at 37°C. The ﬁnal mixture contained 50 or 100 nM TrwC-His6 and 20 nM
plasmid, and the ﬁnal binding buffer contained 30 mM HEPES (pH 7.6) at 25°C, 100 mM NaCl, 5 mM
MgCl2, and 4% glycerol. After incubation, the samples were further processed as described above.
R388 conjugation assay. An overnight culture of TOP10 donor cells (Sm resistant [Smr]) carrying an
R388 plasmid (Tmp resistant [Tmpr]) with wild-type or modiﬁed TrwC (as indicated in Results) was diluted
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20 in LB medium and grown at 37°C until reaching an OD of 0.6. In parallel, an overnight culture of
CSH26Cm::LTL recipient cells (Tcr) was diluted 30 in LB medium and grown at 37°C. Donors corre-
sponding to an OD of 0.3 and recipients corresponding to an OD of 0.6 were spun and resuspended in
50 l of LB. This OD ratio corresponded to 3 recipients per donor. The mixture was pipetted onto a ﬁlter
paper as described for the CRAfT experiments and incubated at 37°C for 1.5 h. The ﬁlter was then placed
into an Eppendorf tube, and cells were washed off by the addition of LB medium and gentle vortexing.
Transconjugants were selected on LB agar plates containing tetracycline and trimethoprim. Donor cell
counts were determined with streptomycin and trimethoprim, and recipient cell counts were determined
with tetracycline. The conjugation frequencies are calculated as transconjugants per donor.
Data availability. All relevant data are available from the authors upon request.
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